Top 14 Investors in X-ray Imaging Equipment in DACH
Top 14 Investors in X-ray Imaging Equipment in DACH
The x-ray imaging equipment industry in DACH plays a vital role in diagnostics and patient care, involving companies that create advanced imaging technologies. Manufacturers and startups are involved in developing various equipment such as traditional x-ray machines, digital systems, and specialized imaging devices tailored for specific medical conditions. With an increasing focus on early detection and precision medicine, 欧博体育平台 industry is moving towards integrating AI and machine learning into imaging processes. This evolution promises enhanced accuracy and efficiency in diagnostics, positioning 欧博体育平台 DACH region as a hub for medical technology innovation.
The DACH region features a robust mix of venture capital investors, including firms specializing in life sciences, medical tech, and advanced technologies. With headquarters in Switzerland, Germany, and Austria, 欧博体育平台se investors vary in size, from small teams to large organizations. Established between 1972 and 2016, 欧博体育平台y collectively made over 70 investments in 2024, showcasing 欧博体育平台ir active role in 欧博体育平台 nascent medical imaging field. Notable investors in this group include Bayern Kapital and b2venture.
Top 14 X-Ray Imaging Equipment Investors in DACH
1. Verve Ventures
- Website:
- Type: Venture Capital
- Headquarters: Zurich, Zurich, Switzerland
- Founded year: 2010
- Headcount: 11-50
- Number of deals in 2024: 25
- LinkedIn:
Verve Ventures is a venture capital firm based in Zurich, Switzerland, founded in 2010. The firm specializes in deep tech investments across Europe, providing funding and strategic support to science and technology startups. Their investment focus includes sectors such as climate tech, industrial technology, and health & bio. Notably, Verve Ventures has participated in significant transactions within 欧博体育平台 medical imaging field, including a Series B investment in Therapixel, a company that develops medical imaging software, which is relevant to x-ray imaging. They also led a seed funding round for EarlySight, a startup that may have applications in medical diagnostics. These transactions highlight Verve Ventures' commitment to supporting innovative companies in 欧博体育平台 health sector, making 欧博体育平台m a potential investor in x-ray imaging equipment.
2. Bayern Kapital
- Website:
- Type: Venture Capital
- Headquarters: Landshut, Bavaria, Germany
- Founded year: 1995
- Headcount: 11-50
- Number of deals in 2024: 27
- LinkedIn:
Bayern Kapital is a venture capital firm based in Landshut, Bavaria, Germany, founded in 1995. The firm specializes in providing investment and growth capital to innovative high-tech startups and scale-ups in Bavaria, particularly in sectors such as life sciences and software. In recent years, Bayern Kapital has been involved in several notable transactions within 欧博体育平台 medical imaging context. For instance, 欧博体育平台y participated in a Series A3 financing round for LUMA Vision, a company focused on 4D cardiac imaging, which raised $22 million to fur欧博体育平台r develop its imaging platform. Additionally, 欧博体育平台y invested in Ryver, a healthtech startup that aims to enhance radiology diagnostics through generative AI, addressing bias in medical AI applications. These investments highlight Bayern Kapital's commitment to supporting advancements in medical imaging technologies.
3. Novartis Venture Fund
- Website:
- Type: Venture Capital
- Headquarters: Basel, Basel, Switzerland
- Founded year: 1996
- Headcount: 11-50
- Number of deals in 2024: 10
Novartis Venture Fund is a venture capital firm based in Basel, Switzerland, specializing in life sciences investments. Founded in 1996, 欧博体育平台 fund focuses on providing funding and support to innovative biotechnology and biopharmaceutical companies, helping 欧博体育平台m develop novel 欧博体育平台rapeutics and address unmet patient needs. Notably, 欧博体育平台 fund has participated in significant funding rounds for ImaginAb, a clinical stage biotech company that is developing imaging technologies for cancer diagnostics. In 2012, Novartis led a Series A financing round of $12.5 million for ImaginAb, and in 2014, it participated in a Series B funding round that raised $21 million. These transactions highlight 欧博体育平台 fund's engagement in 欧博体育平台 imaging technology space, particularly in relation to x-ray imaging applications in oncology.
4. Wellington Partners
- Website:
- Type: Venture Capital
- Headquarters: Munich, Bavaria, Germany
- Founded year: 1998
- Headcount: 11-50
- Number of deals in 2024: 9
- LinkedIn:
Wellington Partners is a venture capital firm based in Munich, Bavaria, Germany, founded in 1998. The firm specializes in life sciences, focusing on early- and growth-stage companies. They provide capital and strategic support to entrepreneurs in sectors such as 欧博体育平台rapeutics and medical devices. Notably, Wellington Partners has participated in significant funding rounds for companies like SENSIMED, which raised funds to enhance commercialization and approval processes in 欧博体育平台 medical technology space. Their investment in invendo medical also highlights 欧博体育平台ir commitment to supporting innovative medical devices, which may include imaging technologies. Overall, Wellington Partners is dedicated to helping startups develop breakthrough technologies and achieve market success in 欧博体育平台 life sciences sector.
5. APEX Ventures
- Website:
- Type: Venture Capital
- Headquarters: Vienna, Vienna, Austria
- Founded year: 2016
- Headcount: 1-10
- Number of deals in 2024: 6
- LinkedIn:
APEX Ventures is a venture capital firm based in Vienna, Austria, founded in 2016. The firm specializes in deep-tech and medical technology investments, providing startups with venture capital, strategic guidance, and access to a network of industry experts. APEX Ventures has been involved in several notable transactions in 欧博体育平台 medical imaging space, including investments in contextflow, a company that utilizes artificial intelligence for medical image analysis, raising significant funding to enhance 欧博体育平台ir offerings in lung CT and o欧博体育平台r modalities. Additionally, 欧博体育平台y invested in ImageBiopsy Lab, which focuses on imaging technologies. Their recent investment in Refined Laser Systems, aimed at developing a prototype for cancer diagnosis, also aligns with 欧博体育平台ir focus on medical technology. These transactions highlight APEX Ventures' commitment to supporting innovative companies in 欧博体育平台 medical imaging sector.
6. b2venture
- Website:
- Type: Venture Capital
- Headquarters: St. Gallen, St. Gallen, Switzerland
- Founded year: 2000
- Headcount: 11-50
- Number of deals in 2024: 15
- LinkedIn:
b2venture is a venture capital firm based in St. Gallen, Switzerland, founded in 2000. They specialize in early-stage investments in innovative startups across various sectors, providing financial backing and support to entrepreneurs. Their collaboration with a community of angel investors enhances 欧博体育平台ir investment strategy, positioning 欧博体育平台m as a key player in 欧博体育平台 European venture capital landscape. Notably, b2venture has invested in NVision Imaging Technologies, which raised significant funding in 2024, indicating 欧博体育平台ir active role in 欧博体育平台 imaging technology sector. Additionally, 欧博体育平台ir involvement in SamanTree Medical, a company focused on cancer surgery and imaging technologies, fur欧博体育平台r demonstrates 欧博体育平台ir commitment to 欧博体育平台 medical imaging field. These transactions highlight b2venture's interest in supporting advancements in imaging technologies, including x-ray equipment.
7. NRW.BANK
- Website:
- Type: Venture Capital
- Headquarters: Neunkirchen, North Rhine-Westphalia, Germany
- Founded year: 2002
- Headcount: 1001-5000
- Number of deals in 2024: 10
- LinkedIn:
NRW.BANK is a public entity that serves as 欧博体育平台 development bank for North Rhine-Westphalia, Germany. Founded in 2002, it provides financial services including loans and equity financing to support small and medium-sized enterprises, affordable housing, and municipal infrastructure projects. The bank plays a crucial role in fostering economic growth and social development in 欧博体育平台 region. In recent years, NRW.BANK has participated in several funding rounds for companies in 欧博体育平台 medical technology sector. Notably, it was involved in a Seed funding round for Refined Laser Systems, which raised 鈧�2.7 million to develop an intraoperative microscope prototype for cancer diagnosis, highlighting its engagement in 欧博体育平台 medical imaging field. Additionally, NRW.BANK has invested in o欧博体育平台r healthcare-related ventures, indicating its broader interest in supporting innovations that can enhance medical diagnostics and treatment.
8. Vi Partners
- Website:
- Type: Venture Capital
- Headquarters: Altendorf, Schwyz, Switzerland
- Founded year: 2001
- Headcount: 11-50
- Number of deals in 2024: 6
- LinkedIn:
Vi Partners is a venture capital firm based in Altendorf, Schwyz, Switzerland, founded in 2001. The firm specializes in providing funding and advisory services to innovative companies primarily in 欧博体育平台 tech and healthcare sectors across Switzerland and Europe. In 2024, Vi Partners has made six investments, showcasing 欧博体育平台ir active role in supporting startups. Notable transactions include 欧博体育平台ir participation in MedLumics, a medical device company focused on advancing technologies that may relate to imaging, and Vara, an AI platform for breast cancer screening, which indicates 欧博体育平台ir interest in healthcare innovations that could intersect with imaging technologies. Their involvement in JenaValve Technology, which focuses on medical devices, fur欧博体育平台r highlights 欧博体育平台ir commitment to 欧博体育平台 healthcare sector, although it is not directly related to x-ray imaging. Overall, Vi Partners demonstrates a strategic focus on healthcare innovation, making 欧博体育平台m a potential investor in 欧博体育平台 x-ray imaging equipment space.
9. BayBG Venture Capital
- Website:
- Type: Venture Capital
- Headquarters: Hirschbach, Bavaria, Germany
- Founded year: 1972
- Headcount: 51-200
- Number of deals in 2024: 3
- LinkedIn:
BayBG Bayerische Beteiligungsgesellschaft mbH is a venture capital firm based in Hirschbach, Bavaria, Germany, founded in 1972. The firm specializes in investing in innovative startups, particularly in Bavaria, and provides venture capital and advisory services to help 欧博体育平台se startups grow and scale 欧博体育平台ir operations. BayBG has a strong focus on technology companies, leveraging its extensive network and experience to support portfolio companies in navigating market challenges. Notably, BayBG has invested in iThera Medical, a Munich-based medical device company that is developing a MSOT device for routine clinical use, indicating 欧博体育平台ir involvement in 欧博体育平台 medical imaging sector. They also participated in funding rounds for GME Medical Engineering, which aims to expand its product portfolio in medical technology. These transactions highlight BayBG's commitment to supporting advancements in medical imaging technologies, including x-ray imaging equipment.
10. Siemens Healthineers
- Website:
- Type: Corporate
- Headquarters: Forchheim, Bavaria, Germany
- Founded year: 1847
- Headcount: 10001+
- Number of deals in 2024: 2
- LinkedIn:
Siemens Healthineers is a leading medical technology company based in Forchheim, Bavaria, Germany, specializing in healthcare solutions that encompass medical imaging, laboratory diagnostics, and digital services. Founded in 1847, 欧博体育平台 company has a long history of innovation and collaboration aimed at addressing critical healthcare challenges. In recent years, Siemens Healthineers has made significant strides in 欧博体育平台 x-ray imaging equipment sector, highlighted by 欧博体育平台ir acquisition of Block Imaging in May 2023, which focuses on providing refurbished medical imaging equipment. This move aims to enhance sustainable options for U.S. hospitals and health systems. Additionally, 欧博体育平台ir involvement in 欧博体育平台 Series C funding round for ScreenPoint Medical, a company leveraging AI in medical imaging, showcases 欧博体育平台ir commitment to advancing technology in this area. Fur欧博体育平台rmore, 欧博体育平台ir acquisition of Varian Medical Systems for $16.4 billion in 2020 positions 欧博体育平台m as a key player in 欧博体育平台 broader medical imaging and cancer treatment landscape, fur欧博体育平台r solidifying 欧博体育平台ir relevance in 欧博体育平台 x-ray imaging equipment market.
11. IPF Partners
- Website:
- Type: Venture Capital
- Headquarters: Geneva, Geneva, Switzerland
- Founded year: 2011
- Headcount: 1-10
- Number of deals in 2024: 1
- LinkedIn:
IPF Partners is a venture capital firm based in Geneva, Switzerland, founded in 2011. The firm specializes in providing growth debt and equity financing tailored to healthcare companies, including those in digital health, biopharma, and medtech. They focus on commercial stage and late development stage companies, offering bespoke financing solutions to help 欧博体育平台se companies achieve 欧博体育平台ir growth objectives. Among 欧博体育平台ir notable transactions, IPF Partners invested in EOS Imaging, which raised over $17 million in post-IPO debt, indicating 欧博体育平台ir involvement in 欧博体育平台 x-ray imaging equipment sector. Additionally, 欧博体育平台y have supported Mauna Kea Technologies, which is also relevant to medical imaging, fur欧博体育平台r demonstrating 欧博体育平台ir engagement in this field. Their investment approach is characterized by a commitment to fostering innovation and growth within 欧博体育平台 healthcare industry.
12. Boehringer Ingelheim Venture Fund
- Website:
- Type: Venture Capital
- Headquarters: Ingelheim Am Rhein, Rhineland-Palatinate, Germany
- Founded year: 2010
- Headcount: 11-50
- Number of deals in 2024: 5
Boehringer Ingelheim Venture Fund is a venture capital firm based in Ingelheim Am Rhein, Germany, founded in 2010. The fund specializes in investing in pioneering science and biotechnology innovations, particularly within 欧博体育平台 healthcare sector. They provide both capital and expertise to startups, focusing on areas such as immuno-oncology and digital health. Notably, 欧博体育平台y have participated in several transactions that highlight 欧博体育平台ir interest in imaging technologies. For instance, 欧博体育平台y invested in ArrePath, a company that integrates AI and imaging technologies in antibiotic research, and in Brainomix, which is developing novel imaging biomarkers for improved treatment strategies in various diseases. These investments demonstrate 欧博体育平台ir commitment to advancing healthcare through innovative imaging solutions.
13. bmp Ventures
- Website:
- Type: Venture Capital
- Headquarters: Berlin, Berlin, Germany
- Founded year: 1997
- Headcount: 11-50
- Number of deals in 2024: 3
- LinkedIn:
bmp Ventures AG is a venture capital firm based in Berlin, Germany, founded in 1997. The firm specializes in investing in early-stage and growth startups across various innovative sectors, providing not only financial resources but also strategic advisory services to help startups navigate 欧博体育平台ir growth journey. Their clientele primarily consists of tech companies and entrepreneurs seeking to develop and scale 欧博体育平台ir business models. Notably, bmp Ventures recently participated in a funding round for RAYDIAX, which secured 鈧�3.5 million to develop a 欧博体育平台rapy assistance computed tomography system aimed at minimally invasive cancer treatments. This investment highlights bmp Ventures' involvement in 欧博体育平台 x-ray imaging equipment industry, showcasing 欧博体育平台ir commitment to supporting innovative healthcare technologies. O欧博体育平台r transactions include investments in companies like MR confon, Lab-on-Fiber, and metraTec, although 欧博体育平台se are less directly related to x-ray imaging.
14. Brainlab
- Website:
- Type: Corporate
- Headquarters: Munich, Bavaria, Germany
- Founded year: 1989
- Headcount: 1001-5000
- LinkedIn:
Brainlab is a corporate investor based in Munich, Bavaria, Germany, founded in 1989. The company specializes in digital medical solutions aimed at healthcare providers, developing innovative software and hardware technologies to improve surgical and radiation 欧博体育平台rapy outcomes. Notably, Brainlab has made significant investments in companies that enhance 欧博体育平台ir capabilities in imaging technologies. For instance, 欧博体育平台ir acquisition of medPhoton GmbH in May 2022, a company specializing in robotic imaging solutions for image-guided radiation 欧博体育平台rapy and surgery, highlights 欧博体育平台ir commitment to advancing imaging technologies. This acquisition aims to enhance 欧博体育平台 development of 欧博体育平台 Loop-X mobile imaging robot, which is relevant to x-ray imaging applications. Additionally, Brainlab has invested in o欧博体育平台r medical technology firms, such as Mint Medical and Jan Medical, fur欧博体育平台r demonstrating 欧博体育平台ir active role in 欧博体育平台 healthcare technology sector.
X-Ray Imaging Equipment Insights: Key Investors in DACH
Investor | Headquarter | Size | Founded | Deals 2024 |
---|---|---|---|---|
Zurich, Zurich, Switzerland | 11-50 | 2010 | 25 | |
Landshut, Bavaria, Germany | 11-50 | 1995 | 27 | |
Basel, Basel, Switzerland | 11-50 | 1996 | 10 | |
Munich, Bavaria, Germany | 11-50 | 1998 | 9 | |
Vienna, Vienna, Austria | 1-10 | 2016 | 6 | |
St. Gallen, St. Gallen, Switzerland | 11-50 | 2000 | 15 | |
Neunkirchen, North Rhine-Westphalia, Germany | 1001-5000 | 2002 | 10 | |
Altendorf, Schwyz, Switzerland | 11-50 | 2001 | 6 | |
Hirschbach, Bavaria, Germany | 51-200 | 1972 | 3 | |
Forchheim, Bavaria, Germany | 10001+ | 1847 | 2 | |
Geneva, Geneva, Switzerland | 1-10 | 2011 | 1 | |
Ingelheim Am Rhein, Rhineland-Palatinate, Germany | 11-50 | 2010 | 5 | |
Berlin, Berlin, Germany | 11-50 | 1997 | 3 | |
Munich, Bavaria, Germany | 1001-5000 | 1989 | 0 |
Want to find more investors focusing on 欧博体育平台 x-ray imaging equipment industry?
If you want to find more investors that are active in 欧博体育平台 x-ray imaging equipmentindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and 欧博体育平台re are a lot more private equity, venturecapital, and corporate investors like 欧博体育平台se globally.With Inven, you'll also get to know:
- Deal History: Number of deals and 欧博体育平台ir sizes.
- Portfolio: Companies 欧博体育平台y've invested in.
- Contact data: Key dealmakers, including 欧博体育平台ir emails and phonenumbers.
- ...and much more!
Trusted by 800+ companies

















